Susan Pereira Ribeiro
Overview
Dr. Susan Pereira Ribeiro is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. She is affiliated with the Pathology Advanced Translational Research Unit (PATRU) and the Winship Cancer Institute of Emory University. Dr. Ribeiro earned her PhD from the University of So Paulo School of Medicine, Brazil, where she also completed a postdoctoral fellowship focusing on HIV vaccine development and immunogenicity evaluation in pre-clinical models. She further extended her studies to HIV pathogenesis during her postdoctoral work at the University of California, San Francisco (UCSF).
Her research interests encompass the role of IL-10 and other factors, such as the microbiome, metabolome, and drugs of abuse, in modulating the immune system in HIV, cancers, COVID-19 and Down syndrome. Dr. Ribeiro's work has contributed to understanding the mechanisms underlying viral persistence and implications for therapeutic interventions.
Research
Publications
-
Delineation of the Human Germinal Centre Immune Landscape Using Multiplex Imaging Analysis.
Immunology
05/27/2025 Authors: Georgakis S; Orfanakis M; Fenwick C; Brenna C; Burgermeister S; Lindsay H; de Medeiros GX; Bruno FR; Ribeiro SP; Gottardo R -
TGF- mediates epigenetic control of innate antiviral responses and SIV reservoir size.
Res Sq
03/19/2025 Authors: Ghneim K; Ten-Caten F; Santana AC; Latif MB; Dinamarca DAD; Garca-Salum T; Estrada PMDR; Sohal P; Strongin Z; Harper J -
Author Correction: Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption.
Nat Immunol Volume: 26 Page(s): 524
03/01/2025 Authors: Pereira Ribeiro S; Strongin Z; Soudeyns H; Ten-Caten F; Ghneim K; Pacheco Sanchez G; Xavier de Medeiros G; Del Rio Estrada PM; Pelletier A-N; Hoang T -
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Nat Commun Volume: 16 Page(s): 586
01/10/2025 Authors: Pickering H; Schaenman J; Phan HV; Maguire C; Tsitsiklis A; Rouphael N; Higuita NIA; Atkinson MA; Brakenridge S; Fung M -
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption.
Nat Immunol Volume: 25 Page(s): 1900 - 1912
10/01/2024 Authors: Pereira Ribeiro S; Strongin Z; Soudeyns H; Ten-Caten F; Ghneim K; Pacheco Sanchez G; Xavier de Medeiros G; Del Rio Estrada PM; Pelletier A-N; Hoang T -
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice.
Sci Transl Med Volume: 16 Page(s): eado1941
08/21/2024 Authors: Desai P; Karl CE; Ying B; Liang C-Y; Garcia-Salum T; Santana AC; Ten-Caten F; Joseph F Urban; Elbashir SM; Edwards DK -
Pediatric immunotherapy and HIV control.
Curr Opin HIV AIDS Volume: 19 Page(s): 201 - 211
07/01/2024 Authors: Chinunga TT; Chahroudi A; Ribeiro SP -
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.
bioRxiv
01/15/2024 Authors: Desai P; Karl CE; Ying B; Liang C-Y; Garcia-Salum T; Santana AC; Caten FT; Urban JF; Elbashir SM; Edwards DK -
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition.
Nat Commun Volume: 15 Page(s): 404
01/09/2024 Authors: Haslund-Gourley BS; Woloszczuk K; Hou J; Connors J; Cusimano G; Bell M; Taramangalam B; Fourati S; Mege N; Bernui M -
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Nat Commun Volume: 15 Page(s): 216
01/03/2024 Authors: Ozonoff A; Jayavelu ND; Liu S; Melamed E; Milliren CE; Qi J; Geng LN; McComsey GA; Cairns CB; Baden LR